OC-0489: TAM and HLA class I expression in relation to HPV and clinical outcome in head and neck cancer. (April 2018) - Ou, D.; Adam, J.; Garberis, I.; Blanchard, P.; Nguyen, F.; Levy, A.; Casiraghi, O.; Gorphe, P.; Breuskin, I.; Janot, F.; Temam, S.; Scoazec, J.; et al.